Professor Stuart Crozier
Professor Stuart Crozier is the Associate Dean (Research) for the Faculty of Engineering, Architecture and Information Technology and Director of Biomedical Engineering at The University of Queensland. His expertise lies in imaging technology, new methods and semi-automated diagnostics. The commercial and academic impact of the work in Magnetic Resonance Imaging has been significant, with about seventy percent of all high-end, clinical MRI systems installed worldwide after 1997 containing patented technology co-invented and developed by him. In 2012 Professor Crozier received the Australian Academy of Technological Sciences (ATSE) Clunies Ross Award for his 20-years of contributions to the field of Magnetic Resonance Imaging. Professor Crozier was also named as one of Australia’s most influential engineers by Engineers Australia in their 2015 “Top 100 Most Influential Engineers” list. He is a Fellow of ISMRM, ATSE and IOP(UK) and a Deputy Editor of Magnetic Resonance in Medicine.
Professor Bas Raaymakers, Department of Radiotherapy, University Medical Center Utrecht
Bas Raaymakers (1972) works as professor experimental clinical physics at the department of Radiotherapy of the University Medical Center Utrecht, The Netherlands. The idea of integrating a radiotherapy accelerator with a 1.5 T MRI was launched and explored together with Jan Lagendijk in the UMC Utrecht. Together with Elekta and Philips a first prototype hybrid MRI accelerator was built to give the proof of concept, a second and third prototype followed. Currently Bas’s main challenge is to translate the MRI accelerator research into the radiotherapy clinic. E.g. MRI based adaptive radiotherapy strategies and fast, on-line plan adaptations.
Michael was the top undergraduate in engineering at Vanderbilt University and later studied medicine at Duke University. He specializes in treating gastrointestinal and thoracic malignancies with stereotactic and adaptive radiation therapy as an assistant professor at Washington University in St. Louis. He serves on a national guideline panels in the United States for stereotactic radiation therapy and for insurance relations. He performs approximately twenty real time MR-guided adaptive treatments a week, particularly for pancreatic, liver, peritoneal, and lung tumors.
Dr Jason Dowling
Dr Jason Dowling is a senior research scientist in the Biomedical Informatics Group at the CSIRO Australian eHealth Research Centre (Brisbane, Australia). He has extensive experience in medical image analysis. Since 2007 he has worked closely with the Calvary Mater Newcastle Hospital on MRI-alone radiation therapy planning.
Yue Cao, Ph.D., has more than 25 years of experience in MRI, including technical development, image analysis and clinical application. She has built and leads a functional imaging group in the Department of Radiation Oncology at University of Michigan since 2003. The research projects of the group have been focused on optimisation of MRI for radiation therapy, geometric distortion characterisation, monitoring and correction of MR images, MRCT creation, physiological parameter quantification, tumor target definition for radiation therapy, tumor and normal tissue response assessment, and physiological-response based adaptation of radiation therapy. Under her leadership, this group has develped an infrastructure for quantitative imaging for radiation therapy. They have been implementing, developing and validating pharmacokinetic models for quantification of Dynamic Contrast Enhanced (DCE) MRI for tumor response assessment in head and neck cancer and glioblastoma, and for liver function and cognitive function assessment during and after radiation therapy. Recently, they have been developing and validating high b-value diffusion weighted imaging for quantification of cellularity and for radiation target definition in glioblastoma. She is a member of the USA NCI Quantitative Imaging Network (QIN) through U01 funding, and participates in collaborative projects for standardisation, validation and utilisation of quantitative imaging. Her research group is funded by USA NIH and industry grants.
Prof Annette Haworth is the Director of the Institute of Medical Physics at Sydney University. Having previously worked as a clinical research physicist at the Peter MacCallum Cancer Centre, she now works across all radiotherapy centres in NSW supporting research and development. Annette has authored more than 70 publications; her research work includes the development of radiological models and advanced imaging techniques for prostate cancer focal brachytherapy. Annette is a past chair of the Australasian Brachytherapy Group (ABG) and co-facilitator of the ABG multidisciplinary Clinical Brachytherapy Workshops. She has been involved and led many interdepartmental, multidisciplinary clinical trial activities.
Scientific Committee Members
Radiation & Imaging Physics
A/Professor Gary Liney
A/Prof Liney is the chair of the 5th MR in RT Symposium and the senior MRI physicist at the Ingham Institute for Applied Medical Research and Liverpool Cancer Therapy Centre. He was recruited from the UK in November 2012 to provide the scientific lead into the MR-simulator and MR-Linac programs at Liverpool hospital having previously worked as a principal radiotherapy physicist in the NHS. His publications include over 50 peer reviewed journal articles and three textbooks. He is also a member of the faculty for the annual ESTRO imaging for physicists course.
Professor Paul Keall
Paul Keall is a Professor in the Sydney Medical School at the University of Sydney and an NHMRC Senior Professorial Research Fellow. Prof. Keall and his team of 20 scientists have the mission to create, share and apply novel cancer imaging and targeted radiotherapy methods that improve human health. His team have achieved significant bench-to-bedside clinical translational milestones in cancer imaging and targeted radiotherapy. Additional programs include the research and development of the Australian MRI-Linear accelerator, and the Nano-X cancer radiotherapy system.
Professor Peter Greer
Peter Greer completed his MSc in medical physics in New Zealand and his PhD at the University of Adelaide, Australia in 2001. He has worked as a radiation oncology medical physicist in New Zealand, Canada and Australia. He currently leads medical physics research at Calvary Mater Newcastle and University of Newcastle. His major areas of research and development interest are electronic portal imaging and MRI-based planning.
Lois Holloway is a radiotherapy physicist working at Liverpool and Macarthur Cancer Therapy Centres and the Ingham Institute where she leads the medical physics research group. She is a member of the Australian MRI-linac steering committee and has research interests in use of MRI information in radiotherapy for improved visualisation and prediction of radiotherapy outcomes.
Professor Uulke A. van der Heide
Uulke van der Heide works as a medical physicist and group leader at the Netherlands Cancer Institute in Amsterdam, the Netherlands. He holds a chair as professor of imaging technology in radiotherapy at the Leiden University. He participates as a teacher on MRI for radiotherapy in the ESTRO school. His research group works on the improvement of target definition in radiotherapy by application of MRI and the development and validation of quantitative imaging methods for tumor characterization for radiotherapy dose painting. He further leads the MR-guided radiotherapy program at the Netherlands Cancer Institute.
A/Professor Tufve Nyholm
Tufve works at Umeå University in Umeå, and Akademiska hospital in Uppsala, both in Sweden. Mainly with research focusing on MRI for planning and guidance of radiotherapy. In Umeå the research group works with a PET/MR scanner dedicated for radiotherapy and in Uppsala the focus is on implementation of an MR-Linac (Atlantic). Nyholm is one of two operating project leaders for the Swedish consortium “Gentle Radiotherapy” is a joint initiative between academia, industry and healthcare aiming at development and implementation of MR based radiotherapy.
Professor James Balter
Dr. Balter is a Radiation Oncology Physicist with primary clinical interests in Image-Guided Radiation Therapy, including the optimal implementation and use of MRI for Radiation Therapy simulation.His primary research focuses on dynamic human modelling, aimed generally at extracting information to update representations of tumor and normal tissue configurations and states as efficiently as possible. He has developed novel image alignment as well as dynamic tomographic image volume reconstruction algorithms, characterized organ movements, and studied the impact of alignment uncertainty on radiation dose, and more recently has worked on development of synthetic CT models of patients to support MRI-only radiation therapy simulation.
Dr. Paulson is a MR physicist cross trained in therapy physics. His primary clinical interest is focused on the optimal implementation of MR simulation. His research is focused on the development and application of advanced MR imaging technologies for MR-guided radiation treatment planning and delivery.
Ms Robba Rai
Robba is the Senior MRI radiographer at the Liverpool Cancer Therapy Centres’ MRI Simulation department, where she has worked since December 2013. She has a Masters in Health Sciences, specialising in Magnetic Resonance Imaging, from the University of Sydney. She also has a level 1 & level 2 MRI accreditations from the Australian Institute of Radiography. Ms Rai is in charge of the training and education of radiation therapists in MRI and is also involved in the implementation and development of MRI protocols for both research and clinical purposes.
Dr Vicky Batumalai
Vikneswary (Vicky) Batumalai is the research radiation therapist at Liverpool Cancer Therapy & Ingham Institute of Applied Medical Research, Australia. Her main research interests include breast radiotherapy and image-guided radiotherapy. In her current role, she has led various research projects, contributing to multiple pieces of work which have been presented at both national and international conferences. Vicky has received a number of awards for her research and presentations, and has numerous peer-reviewed publications. She is currently the acting chair of the Radiation Oncology Research Executive Committee, and is responsible for overseeing all research projects within the department.
Professor Michael Barton
Professor Michael Barton OAM is Foundation Professor of Radiation Oncology at UNSW, and Research Director of the Collaboration for Cancer Outcomes Research and Evaluation (CCORE) and the Ingham Institute for Applied Medical. He is the Director of Research for South West Sydney Local health District. He has chaired reviews of cancer services throughout Australia and overseas resulting in investments in cancer services in Australia of over $1.5 billion. Michael has worked for IAEA on radiotherapy projects in Africa, Asia and Latin America. He chaired the WHO technical document on risk profiling radiotherapy. The benchmarks for radiotherapy service delivery that CCORE developed have now been adopted throughout Australia, Europe and UK. Michael began the Basic Sciences of Oncology Course in NSW which he later developed into the Applied Sciences of Oncology Course for the IAEA.
Professor Cynthia Ménard
Cynthia Ménard is associate clinical professor at the department of radiology, radiation oncology and nuclear medicine at the University of Montreal. The primary focus of Cynthia’s scholarly activity is to better individualize radiation therapy through the development, validation, and clinical application of magnetic resonance imaging techniques to radiation treatment planning, response assessment, and treatment adaptation. She has specifically invested her efforts to improving radiotherapy to the brain and for prostate cancer. She is also affiliated with the Princess Margaret Cancer Centre and the University of Toronto.
A/Professor Piet Dirix
Piet Dirix attained a PhD in medical sciences in 2010 on “Optimization of IMRT for head and neck cancer” and graduated as a radiation oncologist in 2012. He currently works in the Iridium Cancer Network, where his focus lies on pelvic genito-urinary (GU) cancers. He is also an associate professor at Antwerp University and his main research interest is on the use of innovative imaging. The Iridium Cancer Network consists of a close collaboration in radiation oncology, medical oncology and haematology between all 7 Antwerp hospitals. There is only one single radiotherapy department, which treats around 5000 patients per year.
A/Professor Parag Parikh
Parag Parikh is an Associate Professor in Biomedical Engineering and Radiation Oncology at Washington University, St. Louis, Missouri, USA. He also serves as the gastrointestinal cancer service chief in the department. Dr. Parikh’s research interests have been in translating technology, especially that relating to organ position and motion, into clinical trials and practice. He has been involved with implementation of the first integrated MRgRT system, and has the largest clinical experience in daily adaptive MR guided radiation therapy to tumors in the abdomen and pelvis.